The benefit of concurrent chemotherapy with radiotherapy for esophageal cancer is limited in Asian patients aged 80 years or older: a SEER database analysis.
Keiichi JinguNoriyoshi TakahashiRei UmezawaTakaya YamamotoKazuya TakedaYu SuzukiKeita KishidaSo OmataYuta SatoHinako HaradaAyaka HarigaiPublished in: Esophagus : official journal of the Japan Esophageal Society (2022)
It is controversial whether CRT is beneficial for Asian or Pacific Islander patients aged 80 years or older with esophageal cancer based on Analysis of data in SEER database.